New trial of convection enhanced drug delivery (CED) in DIPG- applying the SIOPe DIPG survival prediction model for power calculation.

Ítems similars

• DIPG-16. APPLYING THE SIOPE DIPG REGISTRY SURVIVAL PREDICTION TOOL TO SELECT A SURVIVAL EXTENSION TARGET FOR A POWER CALCULATION FOR A NEW TRIAL OF CONVECTION ENHANCED DRUG DELIVERY (CED) OF CARBOPLATIN AND SODIUM VALPROATE IN DIFFUSE INTRINSIC PONTINE GLIOMA (DIPG)
  per: Szychot, Elwira, et al.
  Publicat: (2019)
• DIPG-82. CLINICAL EXPERIENCE OF CONVECTION ENHANCED DELIVERY (CED) OF CARBOPLATIN AND SODIUM VALPROATE INTO THE PONS FOR THE TREATMENT OF DIFFUSE INTRINSIC PONTINE GLIOMA (DIPG) IN CHILDREN AND YOUNG ADULTS AFTER RADIOTHERAPY
  per: Szychot, Elwira, et al.
  Publicat: (2020)
• DIPG-37. PREDICTING OUTCOME IN CHILDHOOD DIFFUSE MIDLINE GLIOMAS USING MAGNETIC RESONANCE IMAGING BASED TEXTURE ANALYSIS
  per: Szychot, Elwira, et al.
  Publicat: (2020)
• External validation of the diffuse intrinsic pontine glioma survival prediction model: a collaborative report from the International DIPG Registry and the SIOPE DIPG Registry
  per: Veldhuijzen van Zanten, Sophie E. M., et al.
  Publicat: (2017)
• DIPG-84. COMPLEMENTARY AND ALTERNATIVE MEDICINE IN DIFFUSE INTRINSIC PONTINE GLIOMA
  per: El-Khouly, Fatma, et al.
  Publicat: (2020)